Clinical Trials on Post-Treatment in Ireland

Total 119 results

Landspitali University Hospital

Active, not recruiting

The Effects of Antibiotic Exposure in Early Infancy on Vaccine Responses

Antibiotic Treatment | Immune Responses

Iceland
COMPASS Pathways

Completed

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

Treatment Resistant Depression

United States, Ireland
Cork University Hospital

Completed

Analgesic Efficacy of Saphenous Nerve Block in Total Knee Replacement

Post Operative Pain

Ireland
GH Research Ireland Limited

Recruiting

A Trial of GH001 in Patients With Treatment-resistant Depression

Treatment-resistant Depression

Ireland, Germany, Czechia, Spain, Netherlands, Poland
Transcend Therapeutics

Recruiting

A Study to Assess the Use of Methylone in the Treatment of PTSD (IMPACT-1)

Post Traumatic Stress Disorder

United Kingdom, Ireland
University of California, San Francisco
Kenya Medical Research Institute; Organic Health Response; Microclinic International

Completed

Healthy Networks Water Treatment Study (HNWT)

Household Water Treatment | Waterborne Illness

Kenya
Butler Hospital
National Institute of General Medical Sciences (NIGMS)

Recruiting

Exercise to Augment TMS in Those With Treatment Resistant Depression

Treatment Resistant Depression

United States
COMPASS Pathways

Completed

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

Treatment Resistant Depression

United States, Czechia, Netherlands, United Kingdom, Ireland
Transcend Therapeutics

Enrolling by invitation

An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD (IMPACT-EXT)

Post Traumatic Stress Disorder

United Kingdom
Massachusetts General Hospital
National Institute of Mental Health (NIMH); Temple University; Butler Hospital; University of Kansas and other collaborators

Terminated

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (RAPID KOR)

Treatment Resistant Depression

United States
MedtronicNeuro

Completed

Reclaim Deep Brain Stimulation Clinical Study for Treatment-Resistant Depression

Depression

United States
Cork University Hospital

Completed

To Compare lidocaine2%/Clonidine in Combination, With Bupivacaine 0.5 % Alone in Equal Volumes for Combined Sciatic-saphenous Nerve Block in Terms of Selectivity of Blockade

Bimalleolar Fractures of the Ankle. | Sciatic Nerve Block. | Saphenous Nerve Block. | Post Operative Analgesia Duration.

Ireland
University of Dublin, Trinity College
Science Foundation Ireland

Completed

Technology Assisted Solutions for the Recognition of Objective Physiological Indicators of Post-Coronavirus-19 Fatigue (TROPIC)

Covid19 | Post Viral Fatigue

Ireland
Rhode Island Hospital

Completed

A Pilot Gaming Adherence Program for Youth Living With HIV

Adherence to HIV Treatment and Medication

United States
St. James's Hospital, Ireland

Unknown

Sutures Versus Glue in Laparoscopic Port Site Closure. (STILS)

Infection | Cost | Cosmetic Outcome

Ireland
St Vincent's University Hospital, Ireland
PelvEx collaborative

Not yet recruiting

PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting

Locally Advanced Rectal Cancer | Recurrent Rectal Cancer | Multidisciplinary Communication | Multidisciplinary Team Meeting (MDT) | Treatment Decisions

Ireland
COMPASS Pathways

Recruiting

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Treatment Resistant Depression

United States, Spain, Ireland, France, United Kingdom, Canada
Rhode Island Hospital

Recruiting

Family Navigator Intervention

Treatment as Usual | Family Navigator

United States
VA Office of Research and Development

Completed

tDCS Plus Virtual Reality for PTSD (TAVRE)

Post-Traumatic Stress Disorder

United States
Cyberonics, Inc.

Completed

Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses

Depression

United States
Boston VA Research Institute, Inc.
Centers for Disease Control and Prevention

Completed

Strength at Home Couples Program (PTSD-Focused Relationship Enhancement Therapy for Returning Veterans)

Aggression | Post Traumatic Stress Disorders

United States
COMPASS Pathways

Completed

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression (P-TRD)

Treatment Resistant Depression

United States, Netherlands, Ireland, Germany, United Kingdom, Canada, Czechia, Denmark, Portugal, Spain
Health Service Executive, Ireland

Recruiting

Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. (D-FOREST)

Personality Disorders | Cardiovascular Diseases | Obesity | Schizophrenia | Frailty | Recovery | Psychosis | Violence | Type II Diabetes | Treatment-resistant Schizophrenia | Forensic Psychiatry | Outcome Measure

Ireland
Veterans Medical Research Foundation
United States Department of Defense; Brown University; Seattle Institute for... and other collaborators

Recruiting

Trauma Informed Guilt Reduction Therapy (TrIGR)

Post-traumatic Stress Disorders | Guilt | Shame

United States
St. James's Hospital, Ireland

Completed

Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer

Quality of Life | Obesity | Physical Activity | Gastric Cancer | Esophageal Cancer | Sarcopenia | Surgery | Chemotherapeutic Toxicity | Oncology | Sarcopenic Obesity | Visceral Obesity | Complication of Treatment

Ireland
VA Office of Research and Development

Completed

Theta-Burst Neuromodulation for PTSD (TBS)

Chronic Post-Traumatic Stress Disorder

United States
LivaNova

Recruiting

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes (UNCOVER)

Treatment Resistant Depression

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (TRANSFORM-1)

Treatment-resistant Depression

United States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
Janssen Research & Development, LLC

Completed

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-2)

Treatment-resistant Depression

United States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
Rhode Island Hospital
National Institute on Drug Abuse (NIDA)

Completed

Digital Health Intervention to Support Opioid Use Disorder Treatment (iENDURE)

Opioid Use Disorder | Treatment Adherence

United States
Bayer
Nerre Therapeutics Ltd.

Completed

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms (RELENT-1)

Post-menopausal Vasomotor Symptoms

United States
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA); Brown University; Providence VA Medical...

Completed

Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders

Substance-Related Disorders | Stress Disorder, Post-Traumatic

United States
VA Pacific Islands Health Care System
U.S. Army Medical Research and Development Command; University of Hawaii; Pro-Change...

Completed

Computerized Tailored Intervention for Behavioral Sequelae of PTSD in Veterans (CTI-PTSD)

Depression | Smoking | Anxiety | Post Traumatic Stress Disorder

United States
Axsome Therapeutics, Inc.

Completed

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Major Depressive Disorder | Treatment Resistant Depression

United States
Axsome Therapeutics, Inc.

Completed

Mechanistic Evaluation of Response in TRD (MERIT) (MERIT)

Major Depressive Disorder | Treatment Resistant Depression

United States
LivaNova

Recruiting

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER)

Treatment Resistant Depression

United States
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Treatment Resistant Depression

United States
Lifespan
National Institute on Drug Abuse (NIDA)

Recruiting

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

Opioid Use Disorder | Treatment Adherence and Compliance | Criminal Justice

United States
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

A Study in Relapse Prevention of Treatment-Resistant Depression

Treatment Resistant Depression

United States, Argentina, Russian Federation, South Africa, India, Turkey, Puerto Rico, Mexico
VA Office of Research and Development
Providence VA Medical Center

Completed

Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD

Substance Use Disorder | Post-traumatic Stress Disorder | Moral Injury

United States
Carolina Haass-Koffler

Recruiting

MDMA for AUD/PTSD Comorbidity (MDMA)

Post Traumatic Stress Disorder | Alcohol Use Disorder

United States
Axsome Therapeutics, Inc.

Completed

Open-Label Safety Study of AXS-05 in Subjects With Depression

Depression | Major Depressive Disorder | Treatment Resistant Depression

United States
AMAG Pharmaceuticals, Inc.

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

United States
Butler Hospital
National Institute of General Medical Sciences (NIGMS)

Completed

Effect of tDCS Timing on Safety Memory in PTSD

PTSD

United States
Cyberonics, Inc.

Completed

Treatment-Resistant Depression Registry

Major Depressive Disorder

United States
Children's Health Ireland
Belfast Health and Social Care Trust; University of Edinburgh; University Hospital... and other collaborators

Recruiting

Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome (REFRESHED)

Quality of Life | Obstructive Sleep Apnea | Down Syndrome | Behavior | Adherence, Treatment

United Kingdom, Ireland
Novartis Pharmaceuticals

Completed

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

Idiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera Myelofibrosis

United Kingdom, Ireland, Germany, Italy, France
AcelRx Pharmaceuticals, Inc.

Completed

A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain

Post-Operative Pain

United States
VA Office of Research and Development

Completed

Group Treatment for PTSD: A Randomized Clinical Trial With Veterans (GCBT)

PTSD

United States

Clinical Trials on Post-Treatment in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations